摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,3,4-Tri-O-acetyl-1-bromo-D-xylopyranosyl cyanide | 83497-43-2

中文名称
——
中文别名
——
英文名称
2,3,4-Tri-O-acetyl-1-bromo-D-xylopyranosyl cyanide
英文别名
2,3,4-tri-O-acetyl-1-deoxy-1-bromo-β-D-xylopyranosyl cyanide;2,3,4-Tri-O-acetyl-1-bromo-D-xylosyl cyanide;[(3R,4S,5R,6R)-4,5-diacetyloxy-6-bromo-6-cyanooxan-3-yl] acetate
2,3,4-Tri-O-acetyl-1-bromo-D-xylopyranosyl cyanide化学式
CAS
83497-43-2
化学式
C12H14BrNO7
mdl
——
分子量
364.15
InChiKey
PWDCJWOBYXDRAR-KXNHARMFSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.67
  • 拓扑面积:
    112
  • 氢给体数:
    0
  • 氢受体数:
    8

安全信息

  • 海关编码:
    2932999099

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Synthesis of and a Comparative Study on the Inhibition of Muscle and Liver Glycogen Phosphorylases by Epimeric Pairs of d-Gluco- and d-Xylopyranosylidene-spiro-(thio)hydantoins and N-(d-Glucopyranosyl) Amides
    摘要:
    D-Gluco- and D-xylopyranosylidene-spiro-hydantoins and -thiohydantoins were prepared from the parent sugars in a six-step, highly chemo-, regio-, and stereoselective procedure. In the key step of the syntheses C-(1-bromo-1-deoxy-beta -D-glycopyranosyl)formamides were reacted with cyanate ion to give spiro-hydantoins with a retained configuration at the anomeric center as the major products. On the other hand, thiocyanate ions gave spiro-thiohydantoins with an inverted anomeric carbon as the only products. On the basis of radical inhibition studies, a mechanistic rationale was proposed to explain this unique stereoselectivity and the formation of C-(1-hydroxy-beta -D-glycopyranosyl)formamides as byproducts. Enzyme assays with a and b forms of muscle and liver glycogen phosphorylases showed spiro-hydantoin 12 and spiro-thiohydantoin 14 to be the best and equipotent inhibitors with K-i values in the low micromolar range. The study of epimeric pairs of D-gluco and D-Xylo configurated spiro-hydantoins and N-(D-glucopyranosyl)amides corroborated the role of specific hydrogen bridges in binding the inhibitors to the enzyme.
    DOI:
    10.1021/jm010892t
  • 作为产物:
    描述:
    1-deoxy-2,3,4,6-tetra-O-acetyl-β-D-xylopyranosyl cyanideN-溴代丁二酰亚胺(NBS)过氧化氢苯甲酰 作用下, 以 四氯化碳 为溶剂, 以42%的产率得到2,3,4-Tri-O-acetyl-1-bromo-D-xylopyranosyl cyanide
    参考文献:
    名称:
    Bromination of acetylated 2,5-anhydro-aldononitriles at the anomeric centre using N-bromosuccinimide: synthesis of 2,3,4,6-tetra-O-acetyl-1-bromo-d-galactopyranosyl cyanide and its d-xylopyranosyl analogue
    摘要:
    DOI:
    10.1016/s0008-6215(00)80746-6
点击查看最新优质反应信息

文献信息

  • Synthesis and some transformations of 1-azido-glycopyranosyl cyanides-precursors of anomeric α-amino acids
    作者:László Somsák、Erzsébet Sós、Zoltán Györgydeák、Jean-Pierre Praly、Gérard Descotes
    DOI:10.1016/0040-4020(96)00440-1
    日期:1996.7
    Acetylated 1-azido-glycopyranosyl cyanides (of the (1R)- 2, and 16, 5, 7, (1R)- 11, and 12 configurations) and 19 were prepared from acetylated 1-halogeno-d-glycopyranosyl cyanides and formamide, resp., by sodium azide in dimethyl sulfoxide. Acetylated (1S)- 14 and (1R)- 15 1-chloro-d-galactopyranosyl cyanides were obtained from cyanide by lithium chloride in dimethyl sulfoxide. 1,3-Dipolar cycloaddition
    乙酰化的1-叠氮葡萄糖化物(在(1 - [R )- 2,和16,5,7,(1 - [R )- 11和12的配置)和19是从乙酰化制备1 β-卤代-d葡萄糖化物和甲酰胺,分别是叠氮二甲基亚砜中。通过二甲基亚砜中的氯化锂化物获得乙酰化的(1 S)-14和(1 R)-15 1--d-喃半乳糖化物。叠氮化物离子与2的基的1,3-偶极环加成和16得到乙酰化的5-(1-叠氮基-1-脱氧-α-和-β-d-喃半乳糖基)四唑3和17,而乙炔基二羧酸二甲酯到2的叠氮基部分得到乙酰化的1-甲基二甲基。 (1-叠氮基-1-脱氧-β-d-喃半乳糖基)-1,2,3-三唑-4,5-二羧酸20。由乙氧基转化3,得到乙酰化的2-(1-叠氮基-1-脱氧-α-d-喃半乳糖基)-1,3,4-乙二唑-5-羧酸乙酯21。
  • Preparation of acetylated C-(1-bromo-d-glycosyl) heterocycles and 1-bromo-d-glycosyl cyanides
    作者:László Somsák、Gyula Batta、István Farkas
    DOI:10.1016/0008-6215(83)88354-2
    日期:1983.12
    Abstract The reaction of acetylated C -( d -glycosyl) heterocycles and d -glycosyl cyanides with either N -bromosuccinimide in hot carbon tetrachloride or bromine under irradiation resulted in bromination at the anomeric carbon atom. The location of the bromine substituent and the conformations of these products were determined by n.m.r. spectroscopy. Absolute configurations of the bromo compounds
    摘要乙酰化的C-(d-糖基)杂环与d-糖基化物与N-丁二酰亚胺在热四氯化碳中的辐射下反应导致异头碳原子化。取代基的位置和这些产物的构象通过核磁共振光谱法确定。建立了化合物的绝对构型。
  • Preparation of acetylated 1-fluoroglycopyranosyl cyanides
    作者:Viktor Gyóllai、László Somsák、Zoltán Györgydeák
    DOI:10.1016/s0040-4020(98)00813-8
    日期:1998.10
    corresponding inverted 1-fluoroglycosyl cyanides (4 and 6, respectively) together with significant amounts of 1-cyano-2-hydroxy-glycals (9 and 10, respectively). Silver tetrafluoroborate in toluene at room temperature converted 2 and 3 into the 1-fluoroglycosyl cyanides (7 and 8, respectively) of retained anomeric configuration. 1-Chloro-1-deoxy-α-d-galactopyranosyl cyanide (11) also gave 7 with silver fluoride
    β-d-半乳糖(2)和α-d-阿拉伯糖(12)构型的乙酰化1-bromo-1-deoxy-glycopyranosyl化物在室温下与氟化银乙腈中的反应得到相应的1-deoxy-1-fluoroglycopyranosyl化物(分别为5和13),并带有异头中心。在相似的条件下,β-d-葡萄糖(1)和β-d- xylo(3)化合物产生相应的反向1-糖基化物(分别为4和6)以及大量的1-基-2-羟基-糖基(分别为9和10)。室温下在甲苯中的四硼酸将2和3转换为保留的端基异构体构型的1-糖基化物(分别为7和8)。1--1-脱氧-α-d-喃半乳糖化物(11)在回流温度下在乙腈中与氟化银一起得到7。1-脱氧-1--戊喃糖基化物6、8和13的构象平衡反映了基所产生的端基异构作用的反作用。1-脱氧-1--α-d-喃半乳糖被证明是弱竞争抑制剂,如果大肠杆菌β-d-半乳糖苷酶(K
  • Preparation of acetylated 2,6-anhydrohept(hex)-2-enono-nitriles (1-cyano-2-hydroxyglycals)
    作者:László Somsák、Etelka Papp、Gyula Batta、István Farkas
    DOI:10.1016/0008-6215(91)84157-a
    日期:1991.4
  • Korth, Hans-Gert; Praly, Jean-Pierre; Somsak, Laszlo, Chemische Berichte, 1990, vol. 123, # 5, p. 1155 - 1160
    作者:Korth, Hans-Gert、Praly, Jean-Pierre、Somsak, Laszlo、Sustmann, Reiner
    DOI:——
    日期:——
查看更多

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (双(2,2,2-三氯乙基)) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-氨氯地平-d4 (S)-8-氟苯并二氢吡喃-4-胺 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯 (R,S)-可替宁N-氧化物-甲基-d3 (R,S)-六氢-3H-1,2,3-苯并噻唑-2,2-二氧化物-3-羧酸叔丁酯 (R)-(+)-5'-苄氧基卡维地洛 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-卡洛芬 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (R)-4-异丙基-2-恶唑烷硫酮 (R)-3-甲基哌啶盐酸盐; (R)-2-苄基哌啶-1-羧酸叔丁酯 (N-(Boc)-2-吲哚基)二甲基硅烷醇钠 (N-{4-[(6-溴-2-氧代-1,3-苯并恶唑-3(2H)-基)磺酰基]苯基}乙酰胺) (E)-2-氰基-3-(5-(2-辛基-7-(4-(对甲苯基)-1,2,3,3a,4,8b-六氢环戊[b]吲哚-7-基)-2H-苯并[d][1,2,3]三唑-4-基)噻吩-2-基)丙烯酸 (E)-2-氰基-3-[5-(2,5-二氯苯基)呋喃-2-基]-N-喹啉-8-基丙-2-烯酰胺 (8α,9S)-(+)-9-氨基-七氢呋喃-6''-醇,值90% (6R,7R)-7-苯基乙酰胺基-3-[(Z)-2-(4-甲基噻唑-5-基)乙烯基]-3-头孢唑啉-4-羧酸二苯甲基酯 (6-羟基嘧啶-4-基)乙酸 (6,7-二甲氧基-4-(3,4,5-三甲氧基苯基)喹啉) (6,6-二甲基-3-(甲硫基)-1,6-二氢-1,2,4-三嗪-5(2H)-硫酮) (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5R,Z)-3-(羟基((1R,2S,6S,8aS)-1,3,6-三甲基-2-((E)-prop-1-en-1-yl)-1,2,4a,5,6,7,8,8a-八氢萘-1-基)亚甲基)-5-(羟甲基)-1-甲基吡咯烷-2,4-二酮 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-(4-乙氧基-3-甲基苄基)-1,3-苯并二恶茂) (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氯-2,1,3-苯并噻二唑-4-基)-氨基甲氨基硫代甲酸甲酯一氢碘 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (5-氨基-1,3,4-噻二唑-2-基)甲醇 (4aS-反式)-八氢-1H-吡咯并[3,4-b]吡啶 (4aS,9bR)-6-溴-2,3,4,4a,5,9b-六氢-1H-吡啶并[4,3-B]吲哚 (4S,4''S)-2,2''-环亚丙基双[4-叔丁基-4,5-二氢恶唑] (4-(4-氯苯基)硫代)-10-甲基-7H-benzimidazo(2,1-A)奔驰(德)isoquinolin-7一 (4-苄基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (4-己基-2-甲基-4-nitrodecahydropyrido〔1,2-a][1,4]二氮杂) (4,5-二甲氧基-1,2,3,6-四氢哒嗪)